Caballería J
Liver Unit, Hospital Clínic i Provincial, University of Barcelona, Spain.
Clin Ther. 1991 Jul-Aug;13(4):511-20.
It has been demonstrated recently that some portion of ingested alcohol does not enter the systemic circulation and is not retained in the gastrointestinal tract; instead, gastric oxidation or first-pass metabolism of ethanol occurs in the stomach, catalyzed by gastric alcohol dehydrogenase. First-pass metabolism of ethanol is minimal in the fasting state; it is lower in women than in men, and in alcoholics than in nonalcoholics; and it is abolished in patients after subtotal gastrectomy. In addition, some drugs may affect first-pass ethanol metabolism. Studies of the effects of H2-receptor antagonists on blood ethanol levels are reviewed. It is concluded that some H2-receptor antagonists (cimetidine and nizatidine, in particular) can inhibit gastric ethanol oxidation and thus increase blood alcohol levels after drinking. The clinical and medicolegal implications of these findings are discussed.
最近有研究表明,摄入的酒精有一部分并未进入体循环,也未留存于胃肠道;相反,乙醇在胃中会发生胃内氧化或首过代谢,这一过程由胃乙醇脱氢酶催化。乙醇的首过代谢在空腹状态下极少发生;在女性中比在男性中低,在酗酒者中比在非酗酒者中低;在胃大部切除术后的患者中则完全消失。此外,一些药物可能会影响乙醇的首过代谢。本文综述了H2受体拮抗剂对血液乙醇水平影响的研究。得出的结论是,一些H2受体拮抗剂(尤其是西咪替丁和尼扎替丁)能够抑制胃内乙醇氧化,从而在饮酒后提高血液酒精水平。文中讨论了这些研究结果在临床和法医学方面的意义。